UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 24.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,029 shares of the scientific and technical instruments company's stock after acquiring an additional 3,307 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.18% of Transcat worth $1,801,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Jones Financial Companies Lllp increased its holdings in Transcat by 686.7% in the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after purchasing an additional 309 shares in the last quarter. Aquatic Capital Management LLC increased its stake in shares of Transcat by 1,052.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock valued at $122,000 after acquiring an additional 1,052 shares in the last quarter. Morgan Dempsey Capital Management LLC bought a new stake in shares of Transcat in the 4th quarter valued at $143,000. SG Americas Securities LLC acquired a new position in shares of Transcat during the 4th quarter valued at $182,000. Finally, KLP Kapitalforvaltning AS bought a new position in Transcat during the fourth quarter worth $190,000. 98.34% of the stock is owned by institutional investors and hedge funds.
Transcat Trading Down 2.8%
NASDAQ TRNS opened at $77.98 on Friday. The business's fifty day moving average is $82.20 and its 200-day moving average is $88.20. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The stock has a market capitalization of $726.62 million, a price-to-earnings ratio of 42.15 and a beta of 0.75. Transcat, Inc. has a one year low of $67.56 and a one year high of $147.12.
Transcat (NASDAQ:TRNS - Get Free Report) last announced its quarterly earnings data on Monday, May 19th. The scientific and technical instruments company reported $0.64 EPS for the quarter, missing the consensus estimate of $0.66 by ($0.02). Transcat had a return on equity of 7.23% and a net margin of 6.22%. The company had revenue of $77.13 million during the quarter, compared to the consensus estimate of $76.40 million. The firm's revenue for the quarter was up 8.8% compared to the same quarter last year. Equities research analysts predict that Transcat, Inc. will post 2.3 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on TRNS shares. HC Wainwright reiterated a "buy" rating and set a $116.00 price target (up previously from $106.00) on shares of Transcat in a research note on Wednesday, May 21st. Wall Street Zen upgraded shares of Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday, May 28th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $114.00.
View Our Latest Stock Analysis on TRNS
Transcat Company Profile
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
